On August 11, the pharmaceutical network announced on the evening of August 10 that it would acquire 5.1 million shares of hubei xianming medical equipment co., ltd. with its own capital of 5.1 million yuan (51%). The company said that after the acquisition, it has made up its own shortboard in the production and operation of medical devices, and has a positive impact on expanding the company's production and sales in the medical device field.
According to the data, hubei xianming was founded on December 14, 2001, with a registered capital of 10 million yuan, and the business scope is the production and sales of medical devices. At present, the company has 17 product registration certificates, 8 of which are registered, 9 of the secondary registration certificates, and 8 self-owned patents. From January to May 2017, the operating income was 25,80.26 million yuan, and the net profit was -49.78 million yuan, with total assets of 6024.94 million yuan and net assets of RMB 1132.32 million. According to the assessment report, as of May 31, 2017, its shareholders' total equity was 1215.61 million yuan, with an assessment value of RMB 83.28 million and a value-added rate of 7.35%.
|
